NCT06583772 Validity and Reliability of the Virtual Reality-Based 9-Hole Peg Test in Stroke Patients
| NCT ID | NCT06583772 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara University |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 46 participants |
| Start Date | 2023-06-22 |
| Primary Completion | 2025-03-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 46 participants in total. It began in 2023-06-22 with a primary completion date of 2025-03-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to demonstrate diagnostic value of a VR-based 9-hole peg test (9HPT) for the evaluation of manual dexterity in stroke patients. The main questions it aims to answer are: * Is the VR-based 9HPT a reliable and valid diagnostic tool to evaluate manual dexterity in stroke patients when compared to the physical version of it. * Does the VR-based 9HPT differ between the dominant and non-dominant hand in healthy individuals?
Eligibility Criteria
Inclusion Criteria: * Receiving a stroke diagnosis according to the WHO definition * Upper extremity in stage 3 and above according to Brunnstrom motor staging * To be cognitively competent (score of 22 or above on the Mini Mental Test) * Balance of sitting * The patient or his/her relatives have completed the informed voluntary consent form Exclusion Criteria: * Presence of severe aphasia * Presence of cognitive impairment or psychiatric disorders * Detection of a neglect phenomenon * Presence of hemianopsia * Spasticity in the affected arm, 3 or more according to Modified Ashworth Scale
Contact & Investigator
Haydar Gok, Professor
STUDY DIRECTOR
Ankara University
Frequently Asked Questions
Who can join the NCT06583772 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06583772 currently recruiting?
Yes, NCT06583772 is actively recruiting participants. Contact the research team at haydar.gok@gmail.com for enrollment information.
Where is the NCT06583772 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06583772 clinical trial?
NCT06583772 is sponsored by Ankara University. The principal investigator is Haydar Gok, Professor at Ankara University. The trial plans to enroll 46 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.